表紙
市場調査レポート - 240571

総胆管結石症:世界の治験レビュー

Choledocholithiasis Global Clinical Trials Review, H1, 2015

発行 GlobalData
出版日 ページ情報 英文 44 Pages
電子版即納可
価格
総胆管結石症:世界の治験レビュー Choledocholithiasis Global Clinical Trials Review, H1, 2015
出版日: 2015年01月21日 ページ情報: 英文 44 Pages
概要

総胆管結石症とは、総胆管に結石がある状態です。結石は、胆汁顔料またはカルシウムとコレステロール塩類からできています。

当レポートでは、総胆管結石症に関する臨床研究の最新動向について分析し、疾患・治療法の概要や、G7諸国における治験の状況、地域・フェーズ(相)・段階別の進行状況、有望なスポンサー、各企業・研究機関での研究の進行状況、有望な薬剤の比較といった情報を盛り込んで、お届けします。

イントロダクション

  • 総胆管結石症
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • 主要国における治験件数; アジア太平洋地域
    • 主要国における治験件数; 欧州
    • 主要国における治験件数; 北米
    • 主要国における治験件数; 中東/アフリカ地域

G7諸国における治験件数: Choledocholithiasis治験件数の消化管疾患治験件数に対する比率

G7諸国における治験件数:フェーズ(相)別

進捗状況別の治験件数

評価項目別の治験件数

未完了の治験 総胆管結石症

一定期間に採用された被験者数

スポンサーの種類別の治験件数

  • 代表的な研究機関/病院の治験の概要
    • Sydney West Area Health Service
    • Kyungpook National University
    • Arak University of Medical Sciences
    • North Bristol NHS Trust
    • National University Hospital
    • National Taiwan University Hospital
    • University of Thessaly
    • Weill Cornell Medical College
    • Stanford University
    • University of Florida

5大治験プロファイル

付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

GlobalData's clinical trial report, "Choledocholithiasis Global Clinical Trials Review, H1, 2015" provides data on the Choledocholithiasis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Choledocholithiasis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Choledocholithiasis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 3
  • Introduction 4
  • Choledocholithiasis 4
  • Report Guidance 4
  • Clinical Trials by Region 5
  • Clinical Trials and Average Enrollment by Country 6
  • Top Countries Contributing to Clinical Trials in Asia-Pacific 8
  • Top Countries Contributing to Clinical Trials in Europe 9
  • Top Countries Contributing to Clinical Trials in North America 10
  • Top Countries Contributing to Clinical Trials in Middle East and Africa 11
  • Clinical Trials by G7 Countries: Proportion of Choledocholithiasis to Gastrointestinal Clinical Trials 12
  • Clinical Trials in G7 Countries by Trial Status 13
  • Clinical Trials by Trial Status 14
  • Clinical Trials by End Point Status 15
  • Unaccomplished Trials of Choledocholithiasis 16
  • Subjects Recruited Over a Period of Time 18
  • Clinical Trials by Sponsor Type 19
  • Clinical Trial Overview of Top Institutes / Government 20
  • Sydney West Area Health Service 20
  • Clinical Trial Overview of Sydney West Area Health Service 20
  • Kyungpook National University 21
  • Clinical Trial Overview of Kyungpook National University 21
  • Arak University of Medical Sciences 22
  • Clinical Trial Overview of Arak University of Medical Sciences 22
  • North Bristol NHS Trust 23
  • Clinical Trial Overview of North Bristol NHS Trust 23
  • National University Hospital 24
  • Clinical Trial Overview of National University Hospital 24
  • National Taiwan University Hospital 25
  • Clinical Trial Overview of National Taiwan University Hospital 25
  • University of Thessaly 26
  • Clinical Trial Overview of University of Thessaly 26
  • Weill Cornell Medical College 27
  • Clinical Trial Overview of Weill Cornell Medical College 27
  • Stanford University 28
  • Clinical Trial Overview of Stanford University 28
  • University of Florida 29
  • Clinical Trial Overview of University of Florida 29
  • Five Key Clinical Profiles 30

Appendix 42

  • Abbreviations 42
  • Definitions 42
  • Research Methodology 43
  • Secondary Research 43
  • About GlobalData 44
  • Contact Us 44
  • Disclaimer 44
  • Source 44

List of Tables

List of Tables

  • Choledocholithiasis Therapeutics, Global, Clinical Trials by Region, 2015* 5
  • Choledocholithiasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 6
  • Choledocholithiasis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 7
  • Choledocholithiasis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 8
  • Choledocholithiasis Therapeutics Clinical Trials, Europe, Top Countries, 2015* 9
  • Choledocholithiasis Therapeutics Clinical Trials, North America, Top Countries, 2015* 10
  • Choledocholithiasis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 11
  • Proportion of Choledocholithiasis to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 12
  • Choledocholithiasis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 13
  • Choledocholithiasis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 14
  • Choledocholithiasis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 15
  • Choledocholithiasis Therapeutics, Global, Withdrawn Clinical Trials, 2015* 16
  • Choledocholithiasis Therapeutics, Global, Terminated Clinical Trials, 2015* 17
  • Choledocholithiasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 18
  • Choledocholithiasis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 19
  • Choledocholithiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sydney West Area Health Service, 2015* 20
  • Choledocholithiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyungpook National University, 2015* 21
  • Choledocholithiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Arak University of Medical Sciences, 2015* 22
  • Choledocholithiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by North Bristol NHS Trust, 2015* 23
  • Choledocholithiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by National University Hospital, 2015* 24
  • Choledocholithiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2015* 25
  • Choledocholithiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Thessaly, 2015* 26
  • Choledocholithiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Weill Cornell Medical College, 2015* 27
  • Choledocholithiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2015* 28
  • Choledocholithiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Florida, 2015* 29

List of Figures

List of Figures

  • Choledocholithiasis Therapeutics, Global, Clinical Trials by Region (%), 2015* 5
  • Choledocholithiasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 6
  • Choledocholithiasis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 7
  • Choledocholithiasis Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 8
  • Proportion of Choledocholithiasis to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 12
  • Choledocholithiasis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 13
  • Choledocholithiasis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 14
  • Choledocholithiasis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 15
  • Choledocholithiasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 18
  • Choledocholithiasis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 19
  • GlobalData Methodology 43
Back to Top